TIMH
REGN icon

Tilt Investment Management Holdings’s Regeneron Pharmaceuticals REGN Stock Holding History

Tilt Investment Management Holdings’s Portfolio REGN Stock Details REGN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		$384K Sell
437
-129
-23% -$106K 0.41% 67
2023
Q3 		$466K Hold
566
– – 0.33% 90
2023
Q2 		$407K Hold
566
– – 0.27% 99
2023
Q1 		$464K Buy
566
+72
+15% +$54.3K 0.34% 91
2022
Q4 		$356K Buy
+494
New +$365K 0.3% 99

Other funds holding REGN

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
JP Morgan Chase
JP Morgan Chase New York $1.56T AUM 27.86% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Capital International Investors
Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return
Dodge & Cox
Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Tilt Investment Management Holdings's REGN Position: Q4 2023 in Review

Tilt Investment Management Holdings reduced its Regeneron Pharmaceuticals (REGN) stake by 23% in Q4 2023, selling an estimated $106K and leaving 437 shares worth $384K. The position accounts for 0.41% of the portfolio, ranked #67.

Tilt Investment Management Holdings first reported a position in REGN in Q4 2022 and has held it in 5 quarters since. The position peaked at $466K in Q3 2023. 1,273 funds tracked by Wall St. Rank hold REGN as of Q4 2023.

  • Tilt Investment Management Holdings held 437 shares of Regeneron Pharmaceuticals worth $384K as of Q4 2023.
  • Tilt Investment Management Holdings sold 129 Regeneron Pharmaceuticals shares in Q4 2023, an estimated $106K.
  • Regeneron Pharmaceuticals made up 0.41% of Tilt Investment Management Holdings's portfolio in Q4 2023, its #67 holding.
  • Tilt Investment Management Holdings first reported a position in Regeneron Pharmaceuticals in Q4 2022 and has held it in 5 quarters since.
  • Tilt Investment Management Holdings's Regeneron Pharmaceuticals position peaked at $466K in Q3 2023.
  • 1,273 funds tracked by Wall St. Rank held Regeneron Pharmaceuticals as of Q4 2023.

Based on Tilt Investment Management Holdings's 13F filing for Q4 2023, filed 31 Jan 2024.